Mr. Hany Zayed MD, MSc, FRCS Consultant Vascular ...

Mr. Hany Zayed MD, MSc, FRCSConsultant Vascular Surgeon

Guy’s & St. Thomas’ NHS Fountation Trust

LINC, 2021

Clinical Experience between Kissing stents and CERAB

DisclosureSpeaker name: Hany Zayed

.................................................................................

I have the following potential conflicts of interest to report:

Consulting

Employment in industry

Stockholder of a healthcare company

Owner of a healthcare company

Other(s)

I do not have any potential conflict of interest

Speaker name: Hany Zayed

.................................................................................

I have the following potential conflicts of interest to report:

Consulting

Employment in industry

Stockholder of a healthcare company

Owner of a healthcare company

Other(s)

I do not have any potential conflict of interest

Challenges

• Aging population with extensive Co-morbidities ? Fitness for open surgery

• Technical challenges:

Previous surgery

Hostile abdomen

- Metanalysis comparing the outcomes between Kissing Iliac stents, CERAB and open aorto-iliac reconstruction

- Kissing Stents: 32 CERAB: 3

30-days morbidity

30-days mortality

1-Year Primary Patency

1-Year Secondary Patency

3-Year Primary Patency

3-Year Secondary Patency

CERAB-UK

- University Hospitals of Leicester: Mr Robert Davies and Mr Athanasios Saratzis

- Guy’s and St. Thomas’ Hospital: Mr Hany Zayed and Mr Said Abisi

- Lancashire Teaching Hospitals: Dr Bella Huasen and Mr Ensy Egun

- University Hospital Hairmyres: Dr Pui Fong Lau and Miss Jennifer Nash

- Bedfordshire Hospitals: Mr Arindam Chaudhuri and Dr Ramita Dey

- London North-West Hospital: Dr Lorenzo Patrone and Prof. Martin Malina

- 116 Patients with a median follow up of 18 months

- Mean age: 64.4 yrs, 76% were men

- 48% had CLTI and 52% had IC

- 82% had TASC (D) AIOD

- Severely calcified aortic and Iliac lesions in 89.7% and 80.2% respectively

One Year Patency Rates88%

94%

98%

Conclusion

- CERAB and Kissing stents have comparable 30-day Morbidity & Mortality.

- Primary and Secondary patency was acceptable in both techniques.

- Both approaches should be considered in patients with AIOD, especially high-risk.

- More longer term outcome data of CERAB is needed.